Healthcare staffing company AMN Healthcare Services (NYSE:AMN) will be reporting results tomorrow after market close. Here’s what you need to know.
AMN Healthcare Services beat analysts’ revenue expectations by 2.5% last quarter, reporting revenues of $687.5 million, down 19.4% year on year. It was a strong quarter for the company, with a solid beat of analysts’ sales volume estimates.
Is AMN Healthcare Services a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting AMN Healthcare Services’s revenue to decline 15.1% year on year to $694.4 million, improving from the 27.3% decrease it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.49 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. AMN Healthcare Services has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 1.5% on average.
Looking at AMN Healthcare Services’s peers in the healthcare providers & services segment, some have already reported their Q4 results, giving us a hint as to what we can expect. The Ensign Group delivered year-on-year revenue growth of 15.5%, meeting analysts’ expectations, and Centene reported revenues up 3.4%, topping estimates by 4.4%. The Ensign Group traded down 8.7% following the results while Centene was also down 6.3%.
Read our full analysis of The Ensign Group’s results here and Centene’s results here.
Investors in the healthcare providers & services segment have had fairly steady hands going into earnings, with share prices down 2% on average over the last month. AMN Healthcare Services is down 13.7% during the same time and is heading into earnings with an average analyst price target of $37 (compared to the current share price of $23.39).
When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.
